help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TUDER, R. M.
Right arrow Articles by VOELKEL, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TUDER, R. M.
Right arrow Articles by VOELKEL, N. F.

Am. J. Respir. Crit. Care Med., Volume 158, Number 6, December 1998, 1999-2001

Monoclonal Endothelial Cells in Appetite Suppressant-associated Pulmonary Hypertension

RUBIN M. TUDER, ZIVOTIJE RADISAVLJEVIC, KENNETH R. SHROYER, JULIA M. POLAK, and NORBERT F. VOELKEL

Department of Pathology, Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, and Pulmonary Hypertension Center, University of Colorado Health Sciences Center, Denver, Colorado; and Department of Histochemistry, Hammersmith Hospital, Imperial College, London, United Kingdom

Anorexigens such as aminorex fumarate and dexfenfluramine are associated with the development of severe pulmonary hypertension (PH), which clinically and histopathologically is considered indistinguishable from idiopathic or primary pulmonary hypertension (PPH). For the current study, we asked whether anorexigen-associated PH is characterized by monoclonal pulmonary endothelial cell proliferation (such as in PPH) or, alternatively, is associated with a polyclonal endothelial cell proliferation as found in secondary PH. Analysis of clonality by the human androgen receptor assay was performed in microdissected endothelial cells of plexiform lesions of two patients with anorexigen-associated PH. The four plexiform lesions of Patient 1 and the six of Patient 2 with anorexigen-associated PH exhibited a monoclonal expansion of pulmonary endothelial cells, with a mean clonality ratio of 0.03 ± 0.01 SE. Our results indicate that appetite suppressant-associated PH is identical to PPH not only in clinical and histopathologic features but also, at a molecular level, in terms of the monoclonal nature of the endothelial cell proliferation. The anorexigens may accelerate the growth of pulmonary endothelial cells in patients with predisposition to develop PPH.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
S. C. Mathai, R. E. Girgis, M. R. Fisher, H. C. Champion, T. Housten-Harris, A. Zaiman, and P. M. Hassoun
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
Eur. Respir. J., March 1, 2007; 29(3): 469 - 475.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. O. D. Achcar, Y. Demura, P. R. Rai, L. Taraseviciene-Stewart, M. Kasper, N. F. Voelkel, and C. D. Cool
Loss of Caveolin and Heme Oxygenase Expression in Severe Pulmonary Hypertension
Chest, March 1, 2006; 129(3): 696 - 705.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. R. Nicolls, L. Taraseviciene-Stewart, P. R. Rai, D. B. Badesch, and N. F. Voelkel
Autoimmunity and pulmonary hypertension: a perspective
Eur. Respir. J., December 1, 2005; 26(6): 1110 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. E. Girgis, H. C. Champion, G. B. Diette, R. A. Johns, S. Permutt, and J. T. Sylvester
Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 352 - 357.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. D. Machado, V. James, M. Southwood, R. E. Harrison, C. Atkinson, S. Stewart, N. W. Morrell, R. C. Trembath, and M. A. Aldred
Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension
Circulation, February 8, 2005; 111(5): 607 - 613.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. H. Roberts, J. J. Lepore, A. Maroo, M. J. Semigran, and L. C. Ginns
Oxygen Therapy Improves Cardiac Index and Pulmonary Vascular Resistance in Patients With Pulmonary Hypertension
Chest, November 1, 2001; 120(5): 1547 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.M. Tuder, M.E. Yeager, M. Geraci, H.A. Golpon, and N.F. Voelkel
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Eur. Respir. J., June 1, 2001; 17(6): 1065 - 1069.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. D. Cool, J. S. Stewart, P. Werahera, G. J. Miller, R. L. Williams, N. F. Voelkel, and R. M. Tuder
Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific Markers : Evidence for a Dynamic and Heterogeneous Process of PulmonaryEndothelial Cell Growth
Am. J. Pathol., August 1, 1999; 155(2): 411 - 419.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  ATS State of the Art 2009